← FDA DRUG APPROVALS

FDA ANDA · ANDA076570

TRIMETHOBENZAMIDE HYDROCHLORIDE

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA076570
TYPE
ANDA
ORIGINAL APPROVAL
2003-08-28
LATEST ACTION
2020-04-22
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

TRIMETHOBENZAMIDE HYDROCHLORIDEDiscontinued
TRIMETHOBENZAMIDE HYDROCHLORIDE 300MG · CAPSULE · ORAL

Approval history

2020-04-22Labeling · Supplement 18 · standardAP
2010-10-29Labeling · Supplement 11AP
2008-06-18Labeling · Supplement 9AP
2003-08-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →